Research Article
Effect of DLBS1033 on Functional Outcomes for Patients with Acute Ischemic Stroke: A Randomized Controlled Trial
Table 2
Laboratory findings of subjects.
| | Laboratory finding | Median (IQR) | value | | Experimental group () | Control group () | Total () |
| | Hemoglobin (g/L) | 145.5 (99.0-184.0) | 139.0 (99.0-184.0) | 138.0 (80.0-184.0) | 0.547 | | Leucocyte count (×109/L) | 8.2 (5.4-12.8) | 8.0 (5.3-19.2) | 8.8 (3.7-20.4) | 0.895 | | Platelet count (×109/L) | 258.5 (124.0-502.0) | 235.0 (144.0-1291.0) | 263.0 (97.0-1291.0) | 0.181 | | Total cholesterol (mmol/L) | 4.8 (2.8-8.05) | 5.1 (3.3-7.8) | 5.1 (2.7-8.1) | 0.409 | | Urea (mmol/L) | 10.9 (5.5-40.5) | 9.9 (4.4-32.0) | 9.9 (4.3-40.5) | 0.676 | | Creatinine (μmol/L) | 90.6 (56.6-388.1) | 88.4 (41.6-160.9) | 85.8 (41.6-388.1) | 0.826 | | Sodium (mmol/L) | 139.4 (125.9-150.7) | 139.4 (129.9-145.0) | 139.9 (125.9-150.7) | 0.656 | | Potassium (mmol/L) | 3.9 (2.9-5.9) | 3.9 (2.7-5.2) | 3.8 (2.7-5.9) | 0.858 | | Blood glucose (mmol/L) | 7.8 (2.6-41.9) | 7.6 (4.4-18.8) | 7.8 (2.6-41.9) | 0.665 |
|
|
